A.M.E. Nouri

1.3k total citations
62 papers, 1.1k citations indexed

About

A.M.E. Nouri is a scholar working on Immunology, Surgery and Oncology. According to data from OpenAlex, A.M.E. Nouri has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 19 papers in Surgery and 16 papers in Oncology. Recurrent topics in A.M.E. Nouri's work include Immunotherapy and Immune Responses (22 papers), Immune Cell Function and Interaction (13 papers) and Bladder and Urothelial Cancer Treatments (12 papers). A.M.E. Nouri is often cited by papers focused on Immunotherapy and Immune Responses (22 papers), Immune Cell Function and Interaction (13 papers) and Bladder and Urothelial Cancer Treatments (12 papers). A.M.E. Nouri collaborates with scholars based in United Kingdom, Tunisia and United States. A.M.E. Nouri's co-authors include R.T.D. Oliver, R.F. Hussain, G S Panayi, Susan M. Goodman, Duncan A. Gordon, Paul Emery, David L. Crosby, Nicole S. Nicholas, H Cannell and M O Symes and has published in prestigious journals such as British Journal of Cancer, British Journal of Pharmacology and Molecular Pharmacology.

In The Last Decade

A.M.E. Nouri

60 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.M.E. Nouri United Kingdom 16 398 292 200 170 131 62 1.1k
Charlotte Jonsson Sweden 20 308 0.8× 182 0.6× 138 0.7× 177 1.0× 116 0.9× 39 1.0k
Jerry L. McCullough United States 26 373 0.9× 458 1.6× 177 0.9× 102 0.6× 76 0.6× 62 1.9k
Jalil Tavakkol‐Afshari Iran 19 408 1.0× 557 1.9× 396 2.0× 160 0.9× 51 0.4× 55 1.4k
Bhawna Gupta India 19 391 1.0× 435 1.5× 143 0.7× 149 0.9× 32 0.2× 47 1.1k
Katsushi Miura Japan 21 722 1.8× 245 0.8× 142 0.7× 118 0.7× 114 0.9× 56 1.4k
Éva Remenyik Hungary 26 407 1.0× 463 1.6× 355 1.8× 107 0.6× 113 0.9× 92 1.8k
Thai Tran Singapore 23 239 0.6× 412 1.4× 105 0.5× 105 0.6× 138 1.1× 42 1.4k
H. U. Gubler Japan 8 292 0.7× 467 1.6× 154 0.8× 45 0.3× 281 2.1× 10 1.4k
Luis F. Santamaria‐Babí Spain 27 1.0k 2.6× 312 1.1× 164 0.8× 260 1.5× 41 0.3× 68 1.9k
Mansoor Ahmed United Kingdom 17 157 0.4× 372 1.3× 248 1.2× 166 1.0× 70 0.5× 52 1.1k

Countries citing papers authored by A.M.E. Nouri

Since Specialization
Citations

This map shows the geographic impact of A.M.E. Nouri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M.E. Nouri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M.E. Nouri more than expected).

Fields of papers citing papers by A.M.E. Nouri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M.E. Nouri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M.E. Nouri. The network helps show where A.M.E. Nouri may publish in the future.

Co-authorship network of co-authors of A.M.E. Nouri

This figure shows the co-authorship network connecting the top 25 collaborators of A.M.E. Nouri. A scholar is included among the top collaborators of A.M.E. Nouri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M.E. Nouri. A.M.E. Nouri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nouri, A.M.E., et al.. (2025). Reconsidering Pre-Procedural Fasting for Elective Percutaneous Cardiac Procedures. Circulation Cardiovascular Interventions. 18(4). e015089–e015089.
2.
Trabelsi, Saoussen, et al.. (2016). Assessment of MYCN amplification status in Tunisian neuroblastoma: CISH and MLPA combining approach.. PubMed. 93(8-9). 527–31. 2 indexed citations
3.
Sharifpour, I, et al.. (2006). Light and electron microscope of grass carp (Ctenopharyngodon idella) organs following exposure to various sublethal concentrations of diazinon. Iranian journal of fisheries science. 5(2). 111–136. 4 indexed citations
4.
Nouri, A.M.E., et al.. (2002). Comparative Study of Peptides Isolated from Class I Antigen Groove of Urological Specimens. Urologia Internationalis. 68(3). 183–188. 1 indexed citations
5.
Nouri, A.M.E., et al.. (2000). Profile of p53 expression in bladder and oral tumours. European Journal of Cancer. 36(14). 1853–1862. 3 indexed citations
6.
Nouri, A.M.E., et al.. (1999). Profile of Placental Alkaline Phosphatase Expression in Human Malignancies: Effect of Tumour Cell Activation on Alkaline Phosphatase Expression. Urologia Internationalis. 63(3). 168–174. 17 indexed citations
7.
Nouri, A.M.E., et al.. (1998). Comparative expression of major histocompatibility complex (MHC) antigens on CD5+ and CD5− B cells in patients with chronic lymphocytic leukaemia (CLL). European Journal of Cancer. 34(10). 1618–1622. 12 indexed citations
8.
Nouri, A.M.E. & M O Symes. (1998). Relevance of the immune system in human urological malignancies: prospective for future clinical treatments. Urology. 51(5). 41–49. 6 indexed citations
9.
Nouri, A.M.E., Froogh Darakhshan, H Cannell, A. M. I. PARIS, & R.T.D. Oliver. (1996). The relevance of p53 mutation in urological malignancies: possible clinical implications for bladder cancer. British Journal of Urology. 78(3). 337–344. 12 indexed citations
10.
Nouri, A.M.E., R.F. Hussain, Aurelio Santos, & R.T.D. Oliver. (1996). Defective Expression of Adhesion Molecules on Human Bladder Tumour and Human Tumour Cell Lines. Urologia Internationalis. 56(1). 6–12. 5 indexed citations
12.
Nouri, A.M.E., R.F. Hussain, & R.T.D. Oliver. (1995). Epidermal growth factor-induced protection of tumour cell susceptibility to cytolysis. European Journal of Cancer. 31(6). 963–969. 4 indexed citations
13.
Nouri, A.M.E., E. Dorey, Catherine L. Davis, et al.. (1993). Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients. Cancer Immunology Immunotherapy. 37(1). 47–53. 4 indexed citations
14.
Hussain, R.F., A.M.E. Nouri, & R.T.D. Oliver. (1993). A new approach for measurement of cytotoxicity using colorimetric assay. Journal of Immunological Methods. 160(1). 89–96. 287 indexed citations
15.
Nouri, A.M.E., R.F. Hussain, Aurelio Santos, David J. Gillott, & R.T.D. Oliver. (1992). Induction of MHC antigens by tumour cell lines in response to interferons. European Journal of Cancer. 28(6-7). 1110–1115. 13 indexed citations
16.
Nouri, A.M.E., et al.. (1991). CORRELATION BETWEEN EXPRESSION OF CLASS I ANTIGEN AND DEVELOPMENT OF TUMOUR INFILTRATING LYMPHOCYTES (TILS) FROM TUMOUR BIOPSIES OF PATIENTS WITH BLADDER CANCER. The Medical Journal of The Islamic Republic of Iran. 5(1). 9–14. 2 indexed citations
17.
Nouri, A.M.E., et al.. (1991). Correlation between class I antigen expression and the ability to generate tumour infiltrating lymphocytes from bladder tumour biopsies. British Journal of Cancer. 64(6). 996–1000. 4 indexed citations
18.
Nouri, A.M.E., et al.. (1990). Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma. British Journal of Cancer. 62(4). 603–606. 26 indexed citations
19.
Oliver, R.T.D., David L. Crosby, A.M.E. Nouri, Elizabeth Scott, & Andrew Galazka. (1989). Evaluation of the effect of continuous infusion recombinant interleukin-2 (bioleukin) on peripheral blood leucocytes of patients with terminal malignancy. British Journal of Cancer. 60(6). 934–937. 6 indexed citations
20.
Oliver, R.T.D., A.M.E. Nouri, David L. Crosby, et al.. (1989). BIOLOGICAL SIGNIFICANCE OF BETA hCG, HLA AND OTHER MEMBRANE ANTIGEN EXPRESSION ON BLADDER TUMOURS AND THEIR RELATIONSHIP TO TUMOUR INFILTRATING LYMPHOCYTES (TIL). International Journal of Immunogenetics. 16(4-5). 381–390. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026